Are There Any Clinical Trials Involving IRE1 Inhibitors?
Several clinical trials are currently investigating the efficacy of IRE1 inhibitors in various cancers. These trials aim to determine the safety, optimal dosing, and therapeutic potential of these inhibitors, either as monotherapies or in combination with existing cancer treatments. The outcomes of these trials will provide valuable insights into the viability of targeting IRE1 in cancer therapy.
